Sit Investment Associates Inc. Sells 21,085 Shares of Patterson Companies, Inc. (NASDAQ:PDCO)

Sit Investment Associates Inc. decreased its position in Patterson Companies, Inc. (NASDAQ:PDCO) by 84.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,000 shares of the company’s stock after selling 21,085 shares during the period. Sit Investment Associates Inc.’s holdings in Patterson Companies were worth $123,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of PDCO. Values First Advisors Inc. boosted its position in shares of Patterson Companies by 2.9% during the fourth quarter. Values First Advisors Inc. now owns 11,961 shares of the company’s stock valued at $369,000 after buying an additional 337 shares during the last quarter. Huntington National Bank raised its holdings in shares of Patterson Companies by 54.0% during the fourth quarter. Huntington National Bank now owns 1,115 shares of the company’s stock valued at $34,000 after purchasing an additional 391 shares during the last quarter. Anchor Investment Management LLC lifted its position in Patterson Companies by 20.5% during the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company’s stock valued at $51,000 after purchasing an additional 400 shares during the period. Blue Trust Inc. boosted its holdings in Patterson Companies by 18.0% in the fourth quarter. Blue Trust Inc. now owns 2,738 shares of the company’s stock worth $84,000 after purchasing an additional 417 shares during the last quarter. Finally, Spire Wealth Management boosted its holdings in Patterson Companies by 11.2% in the fourth quarter. Spire Wealth Management now owns 4,160 shares of the company’s stock worth $128,000 after purchasing an additional 419 shares during the last quarter. 85.43% of the stock is currently owned by institutional investors.

Patterson Companies Stock Down 0.3 %

PDCO opened at $30.85 on Tuesday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.76 and a current ratio of 1.37. The firm’s fifty day moving average is $31.10 and its 200 day moving average is $26.99. The stock has a market cap of $2.73 billion, a price-to-earnings ratio of 18.04, a price-to-earnings-growth ratio of 2.71 and a beta of 0.73. Patterson Companies, Inc. has a fifty-two week low of $19.45 and a fifty-two week high of $31.79.

Analyst Ratings Changes

Several analysts recently commented on PDCO shares. Robert W. Baird lifted their price objective on Patterson Companies from $25.00 to $31.00 and gave the stock a “neutral” rating in a report on Thursday, December 12th. Leerink Partnrs lowered shares of Patterson Companies from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, December 11th. StockNews.com began coverage on shares of Patterson Companies in a research note on Friday. They issued a “hold” rating on the stock. Morgan Stanley boosted their target price on shares of Patterson Companies from $27.00 to $31.35 and gave the company an “equal weight” rating in a research report on Tuesday, December 17th. Finally, Leerink Partners reiterated a “market perform” rating and set a $31.35 price target (up previously from $29.00) on shares of Patterson Companies in a research note on Wednesday, December 11th. Eleven equities research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.